2021 A Record-Breaking Year for ER and Urgent Care Pioneer

3 years ago

Combined Hybrid ER & Urgent Care Provider Intuitive Health Saw Unprecedented Patient Volume & Exceptional New Market GrowthPLANO, TX /…

CannaPharmaRx Hires Key Personnel to Accelerate Output and Speed to Market for Cannabis Product

3 years ago

CALGARY, AB / ACCESSWIRE / January 19, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient…

iTolerance, Inc. to Present at Virtual Investor 2022 Top Picks Conference

3 years ago

Live video webcast presentation on Wednesday, January 26th at 3:00 PM ETMIAMI, FL / ACCESSWIRE / January 19, 2022 /…

Dynatronics Corporation Announces Brian Baker as Chief Operating Officer

3 years ago

EAGAN, MN / ACCESSWIRE / January 19, 2022 / Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy,…

IM Cannabis announces Focus Medical’s Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel

3 years ago

The successful import demonstrates the strength of the IM Cannabis global supply chain and business modelTORONTO, ON and GLIL YAM,…

1933 Industries Announces Partnership Between Day One Beverages and USA Pickleball Association

3 years ago

Leading CBD Drinks Brand Aligns with USA's Fastest Growing Sport, Keeping Players Refreshed and RevitalizedVANCOUVER, BC / ACCESSWIRE / January…

Philips supports the American Heart Association’s efforts to raise awareness of cardiovascular implantable electronic device (CIED) infections, promote guideline adherence, and improve patient survival rates

3 years ago

Physician talks to patient January 19, 2021  The American Heart Association’s multi-year initiative, supported by Philips, aims to bring forward…

Parexel Named 2022 Catalyst Award Winner

3 years ago

Company honored for commitment to improve gender representation across ranks and promote women to leadership roles BOSTON, and DURHAM, N.C.,…

Orbus Therapeutics’ Phase 3 Eflornithine STELLAR Study Reaches Full Patient Enrollment

3 years ago

- Phase 3 STELLAR trial evaluating eflornithine in patients with recurrent anaplastic astrocytoma - - Pre-specified interim analysis to test for…

Foresight Diagnostics Establishes Scientific Advisory Board with Appointment of Sandra Horning, M.D.

3 years ago

Accomplished academic and industry veteran with a successful record developing treatments for B cell lymphomaAURORA, Colo., Jan. 19, 2022 (GLOBE…